OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Therapeutic drug monitoring
Pharmacogenetic and Pharmacogenomics
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Outcomes
1156 Publications
found
Assessment of Blood Glucose Regulation and Safety of Resistant Starch Formula-Based Diet in Healthy Normal and Subjects With Type 2 Diabetes.
b
Medicine
August 1, 2015
p
Diabetes
c
Change patient management
RCT
Cost-Effectiveness Analysis of a National Newborn Screening Program for Biotinidase Deficiency.
b
Pediatrics
August 1, 2015
p
Newborn Screening
c
Economics
Model
Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial.
b
The Journal of antimicrobial chemotherapy
August 1, 2015
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
RCT
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis.
b
International journal of cardiology
July 15, 2015
p
Cardiovascular Disease
c
Clinical outcomes
Meta-analysis
Review
High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis.
b
Health technology assessment (Winchester, England)
June 1, 2015
p
Cardiovascular Disease
c
Economics
Model
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.
b
Gastroenterology
June 1, 2015
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
RCT
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.
b
Cancer medicine
June 1, 2015
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization.
b
Circulation. Cardiovascular interventions
June 1, 2015
p
Cardiovascular Disease
c
Clinical outcomes
RCT
Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data.
b
The Journal of allergy and clinical immunology
June 1, 2015
p
Newborn Screening
c
Economics
Observational
Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: extended analysis of the PROSE trial.
b
Lung cancer (Amsterdam, Netherlands)
May 1, 2015
p
Cancer
c
Clinical outcomes
Economics
Model
Previous Page
1
…
91
92
93
94
95
…
116
Next Page